Syril Pettit

Rechanneling the cardiac proarrhythmia safety paradigm: A meeting report from the Cardiac Safety Research Consortium

Philip T. Sager, Gary A. Gintant, J. Rick Turner et al. · American Heart Journal · 2013 · 536 citations · Full text

Heart Failure, Cardiac Anaesthesia, White Paper +21

Current challenges in the evaluation of cardiac safety during drug development: Translational medicine meets the Critical Path Initiative

Jonathan P. Piccini, David J. Whellan, Brian R. Berridge et al. · American Heart Journal · 2009 · 125 citations

Drug Safety, Translational Medicine, Heart Failure +12

Biological Qualification of Biomarkers of Chemical-Induced Renal Toxicity in Two Strains of Male Rat

Ernie Harpur, Daniela Ennulat, David Hoffman et al. · Toxicological Sciences · 2011 · 121 citations · Full text

Renal Pathology, Renal Inflammation, Pathology +29

Sources of variation in baseline gene expression levels from toxicogenomics study control animals across multiple laboratories

Michael Boedigheimer, Russell D. Wolfinger, Michael Bass et al. · BMC Genomics · 2008 · 89 citations · Full text

Evaluation of Novel Biomarkers of Nephrotoxicity in Two Strains of Rat Treated with Cisplatin

Jean‐Charles Gautier, Björn Riefke, Jakob Walter et al. · Toxicologic Pathology · 2010 · 87 citations

Renal Lesions, Renal Pathology, Renal Inflammation +19